These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25195857)

  • 1. Prevalence and cost of epilepsy in Sweden--a register-based approach.
    Bolin K; Berggren F; Landtblom AM
    Acta Neurol Scand; 2015 Jan; 131(1):37-44. PubMed ID: 25195857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional variation in prevalence and healthcare utilization due to epilepsy in Sweden.
    Bolin K; Berggren F; Landtblom AM
    Acta Neurol Scand; 2014 Dec; 130(6):354-9. PubMed ID: 25040145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epilepsy in Sweden: health care costs and loss of productivity--a register-based approach.
    Bolin K; Lundgren A; Berggren F; Källén K
    Eur J Health Econ; 2012 Dec; 13(6):819-26. PubMed ID: 22042322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated cost of inpatient admissions and outpatient appointments for a population with epilepsy: a record linkage study.
    Morgan CL; Kerr MP
    Epilepsia; 2004 Jul; 45(7):849-54. PubMed ID: 15230712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
    Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
    Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two methods for estimating the health care costs of epilepsy.
    Frost FJ; Hurley JS; Petersen HV; Gunter MJ; Gause D
    Epilepsia; 2000 Aug; 41(8):1020-6. PubMed ID: 10961630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries.
    Ip Q; Malone DC; Chong J; Harris RB; Labiner DM
    Epilepsy Behav; 2018 Mar; 80():208-214. PubMed ID: 29414554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct medical cost of children and adolescents epilepsy at a university setting in Croatia.
    Prpić I; Boban M; Skarpa-Prpić I; Jurjević A; Babić T; Fiket D
    Coll Antropol; 2009 Jun; 33(2):503-8. PubMed ID: 19662770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Welfare cost of childhood- and adolescent-onset epilepsy: A controlled national study.
    Jennum P; Pickering L; Christensen J; Ibsen R; Kjellberg J
    Epilepsy Behav; 2016 Aug; 61():72-77. PubMed ID: 27317897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epilepsy in tuberous sclerosis patients in Sweden - Healthcare utilization, treatment, morbidity, and mortality using national register data.
    Welin KO; Carlqvist P; Svensson A; Althin R; Eklund E; Rask O
    Seizure; 2017 Dec; 53():4-9. PubMed ID: 29078087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of epilepsy in India.
    Thomas SV; Sarma PS; Alexander M; Pandit L; Shekhar L; Trivedi C; Vengamma B
    Epilepsia; 2001 Aug; 42(8):1052-60. PubMed ID: 11554893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
    Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The direct and indirect costs of epilepsy in Poland estimates for 2014-2016 years.
    Mela A; Staniszewska A; Wrona W; Poniatowski ŁA; Jaroszyński J; Niewada M
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):353-362. PubMed ID: 30293466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic cost of low back pain in Sweden in 2001.
    Ekman M; Johnell O; Lidgren L
    Acta Orthop; 2005 Apr; 76(2):275-84. PubMed ID: 16097556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of epilepsy in Hong Kong: experience from a regional hospital.
    Mak W; Fong JK; Cheung RT; Ho SL
    Seizure; 1999 Dec; 8(8):456-64. PubMed ID: 10627407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of prostate cancer - a Swedish prevalence-based register study.
    Hao S; Östensson E; Eklund M; Grönberg H; Nordström T; Heintz E; Clements M
    BMC Health Serv Res; 2020 May; 20(1):448. PubMed ID: 32434566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of health-care utilization among adult patients with epilepsy in Germany.
    Strzelczyk A; Nickolay T; Bauer S; Haag A; Knake S; Oertel WH; Reif PS; Rosenow F; Reese JP; Dodel R; Hamer HM
    Epilepsy Behav; 2012 Apr; 23(4):451-7. PubMed ID: 22381385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.